Accounts payable $2,911 $2,366
Accrued compensation and benefits 5,269 6,040
Other accrued liabilities 1,926 1,571
Deferred revenue, net 817 720
Total current liabilities 10,923 10,697
Other long term liabilities 1,942 1,996
Total liabilities 12,865 12,693
Stockholders' equity:
Common stock 16 15
Additional paid-in capital 124,362 122,009
Deferred stock compensation (8) (23)
Accumulated other comprehensive income (34) 21
Accumulated deficit (39,638) (48,533)
Total stockholders' equity 84,698 73,489
Total liabilities and stockholders'
equity $97,563 $86,182
VNUS MEDICAL TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)
(unaudited)
Three months ended Six months ended
June 30, June 30,
2008 2007 2008 2007
Net product revenues $21,516 $17,189 $40,392 $32,838
Royalty revenues 10,402 - 10,402 -
Net revenues 31,918 17,189 50,794 32,838
Cost of revenues 7,377 6,830 13,767 11,924
Gross profit
'/>"/>
SOURCE VNUS Medical Technologies, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 Related medicine news :1.
MSU engineering team designs innovative medical device2.
ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference3.
Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract4.
Owner and Operator of Florida Durable Medical Equipment Company Convicted of Medicare Fraud5.
Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach6.
Doctors and medical ethicist discuss whether doctors should participate in capital punishment7.
Preparation for Natural Disasters Critical for People With Diabetes, Chronic Medical Conditions8.
Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment9.
Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments10.
Milestone Scientific Announces Successful Completion of its Collaboration Agreement With Carticept Medical11.
FDA Seeks to Regulate Complementary and Alternative Medicine; Products Such as Vegetable Juice Could Be Restricted for Medical Use